Koyfin Home > Directory > Health Care > Acceleron Pharma > Total Revenue

Acceleron Pharma Total Revenue Chart (XLRN)

Acceleron Pharma annual/quarterly Total Revenue from 2012 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Acceleron Pharma Total Revenue for the quarter ending June 06, 2020 was $40m a 89.41% increase of 36m year over year
  • Acceleron Pharma Total Revenue for the last 12 months ending June 06, 2020 was $88m a 56.10% increase of 49m year over year
  • Acceleron Pharma Annual Total Revenue for 2019 was $74m a 81.09% increase of 60m from 2018
  • Acceleron Pharma Annual Total Revenue for 2018 was $14m a 3.65% increase of 1m from 2017
  • Acceleron Pharma Annual Total Revenue for 2017 was $13m a -106.00% decrease of -14m from 2016
Other Income Statement Metrics:
  • Acceleron Pharma EBITDA for the quarter ending December 12, 2018 was $-36m a 25.58% decrease of -9m year over year
  • Acceleron Pharma Net Income for the quarter ending December 12, 2018 was $-35m a 24.52% decrease of -9m year over year
View Chart On Koyfin

Quarterly XLRN Total Revenue Data

06/2020$40m
03/2020$4m
12/2019$39m
09/2019$4m
06/2019$28m
03/2019$3m
12/2018$4m
09/2018$3m
06/2018$4m
03/2018$3m

Annual XLRN Total Revenue Data

2019$74m
2018$14m
2017$13m
2016$28m
2015$18m
2014$15m
2013$57m
2012$15m
2011$81m